Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Ran...
Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
Background. Efavirenz (EFV) is a highly active antiretroviral drug, use of which is associated with frequent (although transient) neurosensorial adverse reactions. Whether the use of EFV is associated with the risk of depression or suicide remains controversial. Methods. ALIZE-ANRS (Agence Nationale de Recherches sur le SIDA et les Hépatites Virale...
Alternative Titles
Full title
Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_219977802
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_219977802
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1086/504323
